democrat
To sponsor this category, click here | subscribe to this category RSS

Home » Archives for democrat

No Image

Murkowski concedes Senate race in Alaska

Wednesday, September 1st, 2010

LOS ANGELES (MarketWatch) — U.S. Sen. Lisa Murkowski late Tuesday conceded the Alaska Republican primary in her re-election bid to challenger Joe Miller, the Wall Street Journal reported in its online editions

Posted in: headlines | 0 Comments »
Read the full story

The J&J Recall: Will Mr. Weldon Go To Washington?

Tuesday, June 22nd, 2010

Once again, the House Committee on Oversight & Government Reform is asking Johnson & Johnson ceo Bill Weldon to testify about the recent recall of more than 135 million bottles of various pediatric over-the-counter medicines, including Tylenol and Motrin, after a series of ongoing quality-control problems plagued different plants run by J&J’s McNeil Consumer Healthcare unit. UPDATE : As of 6 pm EST, the initial June 30 hearing date has been postponed due to a scheduling conflict. A new date has not been set, taking some heat off Weldon for now

Posted in: Pharma News | 0 Comments »
Read the full story

The UK Plans Price Controls For Medicines

Tuesday, May 25th, 2010

The UK’s new Conservative-Liberal Democrat Coalition has proposed moving to a so-called ‘value-based pricing’ model for medicines, which means drugmakers would no longer be free to set prices. At the same time, a reform of the National Institute for Health and Clinical Excellence, which evaluates cost effectiveness, is also being considered, although details have not yet emerged. The plan comes as other European governments raise drug prices in the face of huge deficits.

Posted in: Pharma News | 0 Comments »
Read the full story

Congress Will Hold J&J Recall Hearing This Week

Saturday, May 22nd, 2010

Despite a request by a fellow committee member to postpone a hearing into the Johnson & Johnson recall scandal, House Committee on Oversight and Government Reform chair Edolphus Towns, a New York Democrat, is proceeding with plans to hold the session this coming Thursday, May 27. You may recall earlier this week that Darrell Issa, the committee’s ranking member and a California Republican, asked Towns for a postponement because J&J ceo Bill Weldon is unable to atttend – he underwent back surgery the other day – and the FDA, meanwhile, has not yet completed its inspections of McNeil Consumer Healthcare facilities. J&J’s McNeil unit was cited for quality-control problems that affected about 40 over-the-counter meds for infants and children, and failed to properly follow up complaints that certain batches of its Tylenol Arthritis Relief Caplets had a musty smell (background here and here ).

Posted in: Pharma News | 0 Comments »
Read the full story
No Image

Anti-Incumbency Fever and the FDA’s Future

Wednesday, May 19th, 2010

Last night came and went, bringing with it what anyone who watches politics pretty much expected. The country is in a mood of “out with the old, in with the new”

Posted in: Regulatory | 0 Comments »
Read the full story

WOW! Brown and Healthcare Reform

Friday, January 22nd, 2010

The tsunami of independent voter discontent evident with the last three elections in Virginia , New Jersey , and in this week’s Scott Brown Massachusetts win means major reconsideration of health care reform. I have called for reform and meaningful reform.

Posted in: DTC, Policy/Law, Regulatory | 0 Comments »
Read the full story

The New York Times, DTC, and Me

Wednesday, August 5th, 2009

Several members of Congress are seeking restrictions on Direct-to-Consumer (DTC) pharmaceutical advertising (see ” Just Say No to Drug Ads, Say Some Lawmakers “).

Posted in: Traditional Channels | 0 Comments »
Read the full story

Should the Tax Deduction for DTC Advertising Expenses be Eliminated?

Wednesday, June 17th, 2009

Rahm Emanuel, president Obama’s Chief of Staff, warned advertising industry leaders some time ago that the business-tax deduction for DTC (direct-to-consumer) spending could be taken away in 2009 tax legislation (see ” Obama, Democrat Win Could Cause Ad Industry ‘Pain’ “). Yesterday, Bloomberg.com quoted House Ways and Means Committee Chairman Charles Rangel as saying “one thing that’s not off the table is you can pick up $37 billion knocking out the deduction for advertising” for prescription drugs (see ” House Considering $37 Billion Drug Tax, Rangel Says “). He was suggesting this as one way to help pay for the pay for a health-care overhaul

Posted in: DTC | 0 Comments »
Read the full story